Correlation Between Bionoid Pharma and Crescita Therapeutics
Can any of the company-specific risk be diversified away by investing in both Bionoid Pharma and Crescita Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bionoid Pharma and Crescita Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bionoid Pharma and Crescita Therapeutics, you can compare the effects of market volatilities on Bionoid Pharma and Crescita Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bionoid Pharma with a short position of Crescita Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bionoid Pharma and Crescita Therapeutics.
Diversification Opportunities for Bionoid Pharma and Crescita Therapeutics
0.11 | Correlation Coefficient |
Average diversification
The 3 months correlation between Bionoid and Crescita is 0.11. Overlapping area represents the amount of risk that can be diversified away by holding Bionoid Pharma and Crescita Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Crescita Therapeutics and Bionoid Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bionoid Pharma are associated (or correlated) with Crescita Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Crescita Therapeutics has no effect on the direction of Bionoid Pharma i.e., Bionoid Pharma and Crescita Therapeutics go up and down completely randomly.
Pair Corralation between Bionoid Pharma and Crescita Therapeutics
If you would invest 10.00 in Bionoid Pharma on September 14, 2024 and sell it today you would earn a total of 17.00 from holding Bionoid Pharma or generate 170.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 95.45% |
Values | Daily Returns |
Bionoid Pharma vs. Crescita Therapeutics
Performance |
Timeline |
Bionoid Pharma |
Crescita Therapeutics |
Bionoid Pharma and Crescita Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Bionoid Pharma and Crescita Therapeutics
The main advantage of trading using opposite Bionoid Pharma and Crescita Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bionoid Pharma position performs unexpectedly, Crescita Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Crescita Therapeutics will offset losses from the drop in Crescita Therapeutics' long position.Bionoid Pharma vs. 4Front Ventures Corp | Bionoid Pharma vs. Khiron Life Sciences | Bionoid Pharma vs. BellRock Brands | Bionoid Pharma vs. Elixinol Global |
Crescita Therapeutics vs. Amexdrug | Crescita Therapeutics vs. The BC Bud | Crescita Therapeutics vs. Antisense Therapeutics Limited | Crescita Therapeutics vs. Cannara Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |